Summary
Oramed Pharma (ORMP) Recent Earnings
Oramed Pharma (ORMP) reported a 1st Quarter November 2020 loss of $0.23 per share on revenue of $0.7 million. The consensus estimate was a loss of $0.16 per share. Sales were flat year-over-year.
Results
Reported Earnings
($0.23)
Earnings Whisper
-
Consensus Estimate
($0.16)
Reported Revenue
$0.7 Mil
Revenue Estimate
Growth
Earnings Growth
Revenue Growth
Earnings Release
